The hyper-consolidation, with little to no regulatory oversight, creates inappropriate negotiating leverage that discourages competition and makes it difficult to achieve transparency, affordability, and timely access for patients.
Menendez criticizes the lack of oversight in the PBM market.
Share
More from Bob Menendez
In recent weeks, the Trump administration and House Republicans have set their sights on the Federal judiciary, calling for unprecedented changes to our courts, attacking the character of dedicated Federal judges, and attempting to…
How do you think--in thinking about the existing infrastructure and making sure that we have an integrated transit system, how do we--should we be thinking about where there are gaps currently in service, or should we be thinking about…
I thank my colleague for yielding. I rise today to pay tribute to the life and legacy of my friend and colleague, Congressman Donald Payne, Jr. Congressman Payne was a fierce advocate and a dedicated public servant who fought tirelessly…
We have been shocked and deeply concerned by the recent breakdown in Amtrak rail operations...
Other voices in this conversation
